Aeterna Zentaris to Present at Upcoming Roth 25th Annual OC Growth Stock Conference
QUÉBEC CITY, March 13, 2013 /PRNewswire/ - Aeterna Zentaris Inc.
(NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its
President and CEO, Juergen Engel, PhD, will be presenting a corporate
overview at the Roth 25th Annual OC Growth Stock Conference on Tuesday, March 19, 2013, at 9:30
am (Pacific), in Track 6: Salon 5-Pink of the Ritz Carlton hotel in
Dana Point, California.
A live webcast of this slide presentation will be available on Aeterna
Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be
available on the Company's website for a period of 90 days.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug development
company currently investigating treatments for various unmet medical
needs. The Company's pipeline encompasses compounds at all stages of
development, from drug discovery through to marketed products. For more
information please visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.
